Molecule neutralising SARS-CoV-2 virus found, could reduce infection duration upon exposure

Updated: Mar 29 2023 12:47PM

Houston, Mar 29 (PTI) The discovery of a small molecule that neutralises the SARS-CoV-2 virus, which causes COVID-19, could provide a new basis for medication to shorten the course of the virus after exposure to it, according to a new study.

Researchers from the University of Houston (UH), US, said that the molecule could provide immediate protection against viral infection and thus, may be suitable for people across age groups, particularly for high-risk and immunocompromised individuals who typically do not generate sufficient antibodies after vaccination.

The molecule worked unlike Pfizer's antiviral treatment Paxlovid, which, they said, was only useful during the first three days of showing symptoms.

Press Trust Of India (PTI) is India's premier news agency, with a reach as vast as the Indian Railways'. It employs nearly 400 journalists and 500 stringers to cover almost every city and small town in India. Collectively, our journalists put out more than 1,000 stories and 250 photographs including graphics every day to feed the appetite of the diverse subscribers, who include the mainstream media, the specialized presses, research groups, companies, and government and non-governmental organizations.

General Access

Add On Customer Packages

The Press Trust Of India Ltd.

PTI building 4, Parliament Street, New Delhi-110 001

© PTI 2021, All Right Reserved

Designed by: 4c Plus